For the last few years, testosterone replacement drug manufacturers have been defending thousands of lawsuits filed by plaintiffs who took the drugs and then suffered from cardiovascular and venous thromboembolic events. Meanwhile, study results on the risks and benefits associated with testosterone
The anticoagulant drug Xarelto (rivaroxaban) is currently the subject of over 15,000 personal injury lawsuits pending in the Eastern District of Louisiana in a consolidated MDL litigation. Plaintiffs in these suits allege that after taking the drug, they suffered excessive bleeding events, and seek
Plaintiffs who file personal injury lawsuits against prescription drug manufacturers typically assert failure to warn claims, which provide that the drug makers failed to provide adequate warnings about the risks associated with their products. Instead, they argue that the manufacturers overstate th
In October 2016, Eliquis manufacturers Bristol-Meyers Squibb and Pfizer Inc. submitted a petition to the U.S. Judicial Panel on Multidistrict Litigation (JPML) to consolidate all Eliquis lawsuits into one court for pre-trial proceedings. They argued at the time that coordination would serve the conv
According to a recent Case Management Order entered in the Xarelto Multidistrict Litigation in federal court (Xarelto MDL), the first Xarelto bellwether trials have been delayed. The U.S. Judicial Panel on Multidistrict Litigation (JPML) consolidated all federally filed Xarelto lawsuits in December
Over the past several months, plaintiffs have been filing product liability lawsuits against Eliquis manufacturers Bristol-Myers Squibb and Pfizer, Inc. As of December 2016, there were about 34 Eliquis lawsuits pending in different courts around the country. In each, plaintiffs claim that the manufa
A Louisiana man has filed a new Xarelto lawsuit on behalf of his spouse, who died after taking the blood-thinning drug. He filed his case in the U.S. District Court for the Eastern District of Louisiana, joining the current Xarelto Multi-District Litigation (MDL) that was…
A new report by the independent, public-interest news organization ProPublica indicates that manufacturers spent more on physician payments for Xarelto than any other drug in 2015. Payments were for things such as promotional speaking, consulting, meals, travel, gifts and royalties, but not for rese
It was over two years ago now that the U.S. Judicial Panel on Multidistrict Litigation (JPML) consolidated all federally filed Xarelto lawsuits into one court in the Eastern District of Louisiana. Now, there are over 13,000 cases pending in that court, with plaintiffs claiming Xarelto…
The number of lawsuits filed against the makers of heartburn drugs like Nexium and Prilosec continues to increase. These drugs belong to a class of medications called “proton pump inhibitors (PPIs)”. They reduce the production of stomach acid and are used to treat acid-related conditions…
On August 26, 2016, an Illinois man filed a new Nexium lawsuit in the U.S. District Court for the Eastern District of New York. He names Nexium manufacturer AstraZeneca as defendant, and claims that after he took the heartburn drug, he suffered from serious injuries.…
The U.S. Judicial Panel on Multidistrict Litigation (JPML) consolidated all federal Xarelto lawsuits into one court in the Eastern District of Louisiana in December 2014. Since then, both sides have been working toward selecting a few key cases to go to trial first, to gauge…